UNDERSTANDING T-CELL SENESCENCE TO OPTIMIZE OVARIAN CANCER IMMUNOTHERAPY

$797,100FY2022Department of the ArmyDOD

Centre Hospitalier Universitaire Vaudois (Chuv)

Investigators